A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 37,996 shares of ASRT stock, worth $37,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,996
Previous 38,551 1.44%
Holding current value
$37,996
Previous $48,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$1.07 - $1.75 $593 - $971
-555 Reduced 1.44%
37,996 $45,000
Q2 2024

Jul 26, 2024

SELL
$0.75 - $1.31 $320 - $559
-427 Reduced 1.1%
38,551 $48,000
Q1 2024

Apr 24, 2024

BUY
$0.79 - $1.14 $15,041 - $21,705
19,040 Added 95.5%
38,978 $37,000
Q4 2023

Feb 09, 2024

BUY
$1.02 - $2.57 $1,938 - $4,883
1,900 Added 10.53%
19,938 $21,000
Q3 2023

Oct 24, 2023

BUY
$2.52 - $5.69 $5,352 - $12,085
2,124 Added 13.35%
18,038 $46,000
Q2 2023

Jul 13, 2023

SELL
$5.0 - $7.66 $22,300 - $34,163
-4,460 Reduced 21.89%
15,914 $86,000
Q1 2023

May 11, 2023

SELL
$3.54 - $6.66 $5,310 - $9,990
-1,500 Reduced 6.86%
20,374 $130,000
Q4 2022

Feb 08, 2023

BUY
$2.11 - $4.3 $11,484 - $23,404
5,443 Added 33.13%
21,874 $94,000
Q3 2022

Oct 17, 2022

BUY
$2.13 - $4.0 $1,491 - $2,800
700 Added 4.45%
16,431 $0
Q2 2022

Jul 13, 2022

BUY
$1.88 - $3.42 $2,820 - $5,130
1,500 Added 10.54%
15,731 $46,000
Q4 2021

Feb 03, 2022

BUY
$0.86 - $2.3 $12,238 - $32,731
14,231 New
14,231 $31,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $48.2M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.